J. Bess

发表

Architecture and Secondary Structure of an Entire HIV-1 RNA Genome

Kristen K. Dang, K. Weeks, Kristen K Dang, 2009, Nature.

Distribution and three-dimensional structure of AIDS virus envelope spikes

J. Lifson, J. Bess, G. Ofek, 2006, Nature.

Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling.

J. Bess, R. Blumenthal, Mathias Viard, 2002, Virology.

Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary Structure

A. Bartesaghi, M. Borgnia, S. Subramaniam, 2010, PLoS pathogens.

Three-Dimensional Structures of Soluble CD4-Bound States of Trimeric Simian Immunodeficiency Virus Envelope Glycoproteins Determined by Using Cryo-Electron Tomography

A. Bartesaghi, M. Borgnia, S. Subramaniam, 2011, Journal of Virology.

Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions

Kenneth A. Taylor, Jun Liu, Kenneth H. Roux, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins.

J. Lifson, W. Alvord, L. Arthur, 2004, AIDS research and human retroviruses.

Inactivation of Retroviruses with Preservation of Structural Integrity by Targeting the Hydrophobic Domain of the Viral Envelope

J. Bess, R. Blumenthal, E. Chertova, 2005, Journal of Virology.

In Vivo Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency Viruses

Taina T. Immonen, L. Picker, J. Lifson, 2019, Journal of Virology.

Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate

R. Desrosiers, J. Lifson, J. Bess, 2015, PloS one.

Maturation of the HIV-1 core by a non-diffusional phase transition

G. A. Frank, S. Subramaniam, Xiongwu Wu, 2015, Nature Communications.

Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.

J. Lifson, L. Arthur, J. Bess, 1998, AIDS research and human retroviruses.

Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA

L. Arthur, R. Gorelick, J. Bess, 1990, Journal of virology.

Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution‐state structure of the nucleocapsid protein from HIV‐1

M. Chance, M. Summers, L. Arthur, 1992, Protein science : a publication of the Protein Society.

Truncating the Gp41 Cytoplasmic Tail of SIV Decreases Sensitivity to 1 Neutralizing Antibodies without Increasing Envelope Content of 2 Virions 3

J. Lifson, J. Bess, E. Chertova, 2017 .

Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy.

J. Lifson, J. Bess, N. Bhardwaj, 2015, Vaccine.

Purification and characterization of the external envelope glycoprotein from two human immunodeficiency virus type 1 variants, HTLV-IIIB and HTLV-IIIRF

L. Arthur, J. Bess, S. Pyle, 1988, Journal of virology.

Alteration of Zinc-Binding Residues of Simian Immunodeficiency Virus p8NC Results in Subtle Differences in Gag Processing and Virion Maturation Associated with Degradative Loss of Mutant NC

R. Gorelick, J. Bess, E. Chertova, 2001, Journal of Virology.

Toll-like receptor 7-adapter complex modulates interferon-α production in HIV-stimulated plasmacytoid dendritic cells

S. Migueles, M. Connors, J. Lifson, 2019, PloS one.

Protection of Macaca nemestrina from Disease following Pathogenic Simian Immunodeficiency Virus (SIV) Challenge: Utilization of SIV Nucleocapsid Mutant DNA Vaccines with and without an SIV Protein Boost

B. M. Flynn, J. Lifson, L. Arthur, 2000, Journal of Virology.

Characterization and molecular cloning of a bovine lentivirus related to human immunodeficiency virus

M. Braun, M. Gonda, L. Arthur, 1987, Nature.

Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells.

L. Arthur, J. Bess, R. Gilden, 1987, AIDS research and human retroviruses.

Ultrasensitive Immunoassay for Simian Immunodeficiency Virus p27

J. Lifson, B. Keele, R. Gorelick, 2018 .

Cryo-EM structures of prefusion SIV envelope trimer

J. Lifson, B. Keele, M. Roederer, 2022, Nature Structural & Molecular Biology.

Binding, internalization, and membrane incorporation of human immunodeficiency virus-1 at the blood–brain barrier is differentially regulated

S. M. Robinson, W. Banks, L. Arthur, 2004, Neuroscience.

Defining HIV and SIV Reservoirs in Lymphoid Tissues

J. Lifson, A. Haase, J. McCune, 2016, Pathogens & immunity.

Asymmetric HIV-1 envelope trimers bound to one and two CD4 molecules are intermediates during membrane binding

H. Tagare, J. Lifson, P. Uchil, 2022, bioRxiv.

Envelope Glycoprotein Incorporation, Not Shedding of Surface Envelope Glycoprotein (gp120/SU), Is the Primary Determinant of SU Content of Purified Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus

J. Hoxie, J. Lifson, L. Arthur, 2002, Journal of Virology.

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120

L. Arthur, J. Bess, R. Gallo, 1989, Journal of virology.

Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.

L. Arthur, R. Gorelick, J. Bess, 1997, Virology.

Actinomycin D Inhibits Human Immunodeficiency Virus Type 1 Minus-Strand Transfer in In Vitro and Endogenous Reverse Transcriptase Assays

J. Bess, J. G. Levin, L. Henderson, 1998, Journal of Virology.

Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds

M. Summers, L. Arthur, J. Bess, 1993, Nature.

Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses

H. Issaq, L. Arthur, J. Bess, 1992, Journal of virology.

Candida albicans-Induced DC Activation Partially Restricts HIV Amplification in DCs and Increases DC to T-Cell Spread of HIV

J. Lifson, J. Bess, L. Vachot, 2008, Journal of acquired immune deficiency syndromes.

Proteomic and Biochemical Analysis of Purified Human Immunodeficiency Virus Type 1 Produced from Infected Monocyte-Derived Macrophages

K. Nagashima, T. Veenstra, J. Lifson, 2006, Journal of Virology.

Efficacy of Carraguard®-Based Microbicides In Vivo Despite Variable In Vitro Activity

A. Gettie, J. Blanchard, J. Lifson, 2008, PloS one.

Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120).

L. Arthur, J. Bess, S. Pyle, 1989, Vaccine.

Differential Incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and Major Histocompatibility Complex Class I and II Molecules into Human Immunodeficiency Virus Type 1 Virions and Microvesicles: Implications for Viral Pathogenesis and Immune Regulation

J. Lifson, L. Arthur, J. Bess, 2001, Journal of Virology.

Development of the bovine immunodeficiency-like virus as a model of lentivirus disease.

K. Nagashima, M. Gonda, J. Bess, 1990, Developments in biological standardization.

Large-scale purification of gp70 from Moloney murine leukemia virus.

L. Arthur, J. Bess, S. Pyle, 1991, Journal of virological methods.

Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences

L. Arthur, C. Fenselau, J. Bess, 1992, Journal of virology.

Double-Stranded RNA Analog Poly(I:C) Inhibits Human Immunodeficiency Virus Amplification in Dendritic Cells via Type I Interferon-Mediated Activation of APOBEC3G

J. Lifson, J. Bess, S. Turville, 2008, Journal of Virology.

Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins

Q. Sattentau, J. Lifson, L. Arthur, 1998, Journal of Virology.

A Fusion Inhibitor Prevents Spread of Immunodeficiency Viruses, but Not Activation of Virus-Specific T Cells, by Dendritic Cells

A. Gettie, J. Lifson, J. Bess, 2008, Journal of Virology.

Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome

K. Weeks, Christopher W Leonard, R. Gorelick, 2010, Proceedings of the National Academy of Sciences.

Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS

J. Lifson, M. Piatak, J. Bess, 2005, Journal of medical primatology.

Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus

J. Strominger, L. Arthur, J. Bess, 1995, Journal of virology.

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.

L. Arthur, J. Chermann, J. Bess, 1992, Science.

Truncating the gp41 Cytoplasmic Tail of Simian Immunodeficiency Virus Decreases Sensitivity to Neutralizing Antibodies without Increasing the Envelope Content of Virions

J. Lifson, J. Bess, E. White, 2017, Journal of Virology.

Evidence that the species barrier of human immunodeficiency virus-1 does not extend to uptake by the blood--brain barrier: comparison of mouse and human brain microvessels.

W. Banks, L. Arthur, J. Bess, 2005, Life sciences.

Partial Activation and Induction of Apoptosis in CD4+ and CD8+ T Lymphocytes by Conformationally Authentic Noninfectious Human Immunodeficiency Virus Type 1

J. Lifson, L. Arthur, J. Bess, 2001, Journal of Virology.

Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes

J. Lifson, D. Venzon, J. Bess, 2018, PLoS pathogens.

Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responses.

J. Lifson, M. Robb, D. Birx, 2007, AIDS research and human retroviruses.

3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells

Bradley C. Lowekamp, K. Nagashima, S. Subramaniam, 2010, Proceedings of the National Academy of Sciences.

Control of Viremia and Prevention of Simian-Human Immunodeficiency Virus-Induced Disease in Rhesus Macaques Immunized with Recombinant Vaccinia Viruses plus Inactivated Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 1 Particles

J. Lifson, L. Arthur, M. Piatak, 2003, Journal of Virology.

Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen

David J. Harvey, Weston B. Struwe, Brandon F. Keele, 2018, Cell reports.

Subnanometer structures of HIV-1 envelope trimers on aldrithiol-2-inactivated virus particles

Daniel S. Terry, J. Lifson, Baoshan Zhang, 2020, Nature Structural & Molecular Biology.

Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA

J G Levin, J. Bess, J. G. Levin, 1997, Journal of virology.

HIV-1 and microvesicles from T-cells share a common glycome, arguing for a common origin

K. Nagashima, J. Bess, Lakshmi Krishnamoorthy, 2009, Nature chemical biology.

HLA class II on HIV particles is functional in superantigen presentation to human T cells: implications for HIV pathogenesis.

P. Cresswell, L. Arthur, J. Bess, 1995, AIDS research and human retroviruses.

Restricted Replication of Xenotropic Murine Leukemia Virus-Related Virus in Pigtailed Macaques

K. Nagashima, V. Pathak, J. Lifson, 2012, Journal of Virology.

Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies

L. Arthur, J. Bess, S. Pyle, 1988, Journal of virology.

DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge

N. Sardesai, J. Lifson, D. Venzon, 2013, Proceedings of the National Academy of Sciences.

Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challenge

R. Desrosiers, L. Arthur, M. Piatak, 2002, Journal of medical primatology.

Mapping the complete glycoproteome of virion-derived HIV-1 gp120 provides insights into broadly neutralizing antibody binding

R. Desrosiers, J. Lifson, B. Keele, 2016, Scientific Reports.

Extended x-ray absorption fine structure studies of a retrovirus: equine infectious anemia virus cysteine arrays are coordinated to zinc.

M. Chance, L. Arthur, J. Bess, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Molecular Requirements for Human Immunodeficiency Virus Type 1 Plus-Strand Transfer: Analysis in Reconstituted and Endogenous Reverse Transcription Systems

J. Bess, J. G. Levin, L. Henderson, 1999, Journal of Virology.

DNA and Protein Co-Immunization Improves the Magnitude and Longevity of Humoral Immune Responses in Macaques

N. Sardesai, D. Montefiori, J. Lifson, 2014, PloS one.

Electron Tomography of the Contact between T Cells and SIV/HIV-1: Implications for Viral Entry

Sriram Subramaniam, Adam E Bennett, Alberto Bartesaghi, 2007, PLoS pathogens.

Elimination of Retroviral Infectivity by N-Ethylmaleimide with Preservation of Functional Envelope Glycoproteins

David E. Ott, David R. Morcock, Robert J. Gorelick, 2005, Journal of Virology.

Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239

A. Gettie, J. Lifson, M. Piatak, 2009, Journal of acquired immune deficiency syndromes.

In Vivo Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency Viruses

L. Picker, J. Lifson, C. Fennessey, 2019, Journal of Virology.

Ultrasensitive Immunoassay for Simian Immunodeficiency Virus p27CA.

J. Lifson, B. Keele, R. Gorelick, 2018, AIDS research and human retroviruses.

Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.

M. Gonda, L. Arthur, J. Bess, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Correction: Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes

J. Lifson, D. Venzon, J. Bess, 2018, PLoS Pathogens.

Ultrasensitive Immunoassay for Simian Immunodeficiency Virus p27CA.

J. Lifson, B. Keele, R. Gorelick, 2018, AIDS research and human retroviruses.

Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins.

J. Lifson, J. Bess, E. Chertova, 2003, Current molecular medicine.

Truncating the gp41 Cytoplasmic Tail of Simian Immunodeficiency Virus Decreases Sensitivity to Neutralizing Antibodies without Increasing the Envelope Content of Virions

J. Lifson, J. Bess, E. White, 2017, Journal of Virology.

HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes

H. Tagare, J. Lifson, P. Uchil, 2023, Nature.